Buvidal: is it really a ‘game changer’ in the treatment of problematic opioid use?

dc.contributor.author	Holloway, Kate
dc.contributor.author	Schifano, Fabrizio
dc.date.accessioned	2024-03-25T13:34:54Z
dc.date.available	2024-03-25T13:34:54Z
dc.date.issued	2023-11-30
dc.identifier.citation	Holloway , K & Schifano , F 2023 , ' Buvidal: is it really a ‘game changer’ in the treatment of problematic opioid use? ' The Conversation . < https://theconversation.com/buvidal-is-it-really-a-game-changer-in-the-treatment-of-problematic-opioid-use-214895 >
dc.identifier.uri	http://hdl.handle.net/2299/27654
dc.description	This is an open access article distributed under the terms of the Creative Commons Attribution-No Derivatives 4.0 International License (CC BY-ND), https://creativecommons.org/licenses/by/4.0/
dc.format.extent	605693
dc.language.iso	eng
dc.relation.ispartof	The Conversation
dc.subject	Buvidal
dc.subject	Buprenorphine
dc.subject	Depot injection
dc.title	Buvidal: is it really a ‘game changer’ in the treatment of problematic opioid use?	en
dc.contributor.institution	Department of Clinical, Pharmaceutical and Biological Science
dc.contributor.institution	Centre for Health Services and Clinical Research
dc.contributor.institution	Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institution	School of Life and Medical Sciences
dc.identifier.url	https://theconversation.com/buvidal-is-it-really-a-game-changer-in-the-treatment-of-problematic-opioid-use-214895
rioxxterms.type	Other
herts.preservation.rarelyaccessed	true